Literature DB >> 26637769

Choosing a systemic treatment for advanced stage cutaneous T-cell lymphoma: mycosis fungoides and Sézary syndrome.

Madeleine Duvic1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26637769     DOI: 10.1182/asheducation-2015.1.529

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


× No keyword cloud information.
  4 in total

Review 1.  Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome.

Authors:  Louise Photiou; Carrie van der Weyden; Christopher McCormack; H Miles Prince
Journal:  Curr Oncol Rep       Date:  2018-03-23       Impact factor: 5.075

2.  The pivotal role of cytotoxic NK cells in mediating the therapeutic effect of anti-CD47 therapy in mycosis fungoides.

Authors:  Oleg Kruglov; Lisa D S Johnson; Angela Minic; Kimberly Jordan; Robert A Uger; Mark Wong; Eric L Sievers; Yaping Shou; Oleg E Akilov
Journal:  Cancer Immunol Immunother       Date:  2021-09-14       Impact factor: 6.968

3.  The synergistic proapoptotic effect of PARP-1 and HDAC inhibition in cutaneous T-cell lymphoma is mediated via Blimp-1.

Authors:  Oleg Kruglov; Xuesong Wu; Sam T Hwang; Oleg E Akilov
Journal:  Blood Adv       Date:  2020-10-13

4.  Durable Resolution of Severe Psoriasis in a Patient Treated with Pentostatin for Hairy Cell Leukemia: A Case Report.

Authors:  Tamim Alsuliman; Kaiss Lassoued; Maifa Belghoul; Karima Debbache; Bachra Choufi
Journal:  Dermatol Ther (Heidelb)       Date:  2017-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.